0000000000872052

AUTHOR

Reposi Investigators

showing 3 related works from this author

Gender difference in drug use in hospitalized elderly patients.

2015

Purpose The aims of this study were to evaluate whether or not there are gender differences in drug use at hospital admission and prescription at discharge and to evaluate the effect of hospitalization on medication patterns in the elderly. Method In-patients aged > 65 years included in the REPOSI registry during a recruitment period of 3 years (2008-2010-2012) were analyzed in order to evaluate drug use at hospital admission and prescription at discharge according to gender. Results A total of 3473 patients, 52% women and 48% men, were considered. Polypharmacy (> 5 drugs) is more frequent in men both at hospital admission and discharge. At hospital discharge, the number of prescripti…

DrugMalePediatricsmedicine.medical_specialtySettore MED/09 - Medicina Internamedia_common.quotation_subjectSocio-culturaleDrug Prescriptionselderly gender polypharmacyElderlyAge groupsDrug PrescriptionHospital dischargeInternal MedicineMedicineHumansMedical prescriptionSex DistributionPrescribed drugsmedia_commonAgedElderly; Gender; Polypharmacy; Internal MedicinePolypharmacyAged 80 and overSex Characteristicsbusiness.industryGenderSex CharacteristicPatient DischargeHospitalizationHospital admissionPolypharmacyFemalebusinessSex characteristicsHumanEuropean journal of internal medicine
researchProduct

Prevalence of older in-patients at risk of clopidogrel resistance according to the STIB score. Results from REPOSI registry

2017

The phenomenon of resistance to copidogrel catches the attention of a growing number of clinicians because of its frequency and the severity of adverse events related to it. The identification of patients with high platelet reactivity (HPR may help to improve their therapy applying the concept of personalized medicine, most important in the older people treated with polypharmacy. The existece of such a simple clinical method as the STIB score, that allows to predict the possible resistace to clopidogrel at the bedside without using expensive laboratory investigations, provides an attractive approach to the problem.

Blood Plateletsmedicine.medical_specialtyTiclopidineSettore MED/09 - Medicina InternaHPRTreatment outcomeMEDLINEClopidogrel resistance030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicinePrevalenceInternal MedicinemedicineClopidogrel resistance HPR STIB score REPOSIHumansIn patientPlateletRegistriesSTIB score030212 general & internal medicineTiclopidineClopidogrel resistance; HPR; REPOSI; STIB score; Internal Medicinebusiness.industryClopidogrel resistanceREPOSISurgeryTreatment OutcomePlatelet aggregation inhibitorbusinessPlatelet Aggregation Inhibitorsmedicine.drug
researchProduct

Pain and Frailty in Hospitalized Older Adults

2020

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.

researchProduct